Longeveron Inc. Announces Special Meeting for Reverse Stock Split Vote

Ticker: LGVN · Form: DEF 14A · Filed: Feb 5, 2024 · CIK: 1721484

Longeveron INC. DEF 14A Filing Summary
FieldDetail
CompanyLongeveron INC. (LGVN)
Form TypeDEF 14A
Filed DateFeb 5, 2024
Risk Level
Pages15
Reading Time18 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: Longeveron, LGVN, Reverse Stock Split, Special Meeting, Proxy Statement

TL;DR

<b>Longeveron Inc. is holding a special meeting on February 21, 2024, to vote on a reverse stock split proposal ranging from 1:5 to 1:15.</b>

AI Summary

Longeveron Inc. (LGVN) filed a Proxy Statement (DEF 14A) with the SEC on February 5, 2024. Longeveron Inc. will hold a Special Meeting of Stockholders on February 21, 2024, virtually. The primary proposal is to approve an amendment to the certificate of incorporation for a reverse stock split. The reverse stock split ratio will range from 1-for-5 to 1-for-15, determined by the Board of Directors. A second proposal concerns adjourning the meeting if necessary to solicit more votes for the reverse stock split. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

For investors and stakeholders tracking Longeveron Inc., this filing contains several important signals. The reverse stock split is likely intended to increase the per-share trading price of Longeveron's common stock, potentially to meet stock exchange listing requirements or improve investor perception. The adjournment proposal provides flexibility to ensure the company can achieve the necessary stockholder approval for the reverse stock split, indicating potential concern about securing sufficient votes.

Risk Assessment

Risk Level: — Longeveron Inc. shows moderate risk based on this filing. The company is seeking approval for a reverse stock split, which can be a sign of financial distress or a strategy to avoid delisting, but the specific ratio and board discretion introduce uncertainty.

Analyst Insight

Stockholders should carefully consider the implications of a reverse stock split on their investment and vote on the proposals presented at the Special Meeting.

Key Numbers

Key Players & Entities

FAQ

When did Longeveron Inc. file this DEF 14A?

Longeveron Inc. filed this Proxy Statement (DEF 14A) with the SEC on February 5, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Longeveron Inc. (LGVN).

Where can I read the original DEF 14A filing from Longeveron Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Longeveron Inc..

What are the key takeaways from Longeveron Inc.'s DEF 14A?

Longeveron Inc. filed this DEF 14A on February 5, 2024. Key takeaways: Longeveron Inc. will hold a Special Meeting of Stockholders on February 21, 2024, virtually.. The primary proposal is to approve an amendment to the certificate of incorporation for a reverse stock split.. The reverse stock split ratio will range from 1-for-5 to 1-for-15, determined by the Board of Directors..

Is Longeveron Inc. a risky investment based on this filing?

Based on this DEF 14A, Longeveron Inc. presents a moderate-risk profile. The company is seeking approval for a reverse stock split, which can be a sign of financial distress or a strategy to avoid delisting, but the specific ratio and board discretion introduce uncertainty.

What should investors do after reading Longeveron Inc.'s DEF 14A?

Stockholders should carefully consider the implications of a reverse stock split on their investment and vote on the proposals presented at the Special Meeting. The overall sentiment from this filing is neutral.

How does Longeveron Inc. compare to its industry peers?

Longeveron Inc. operates in the pharmaceutical preparations industry, focusing on developing therapies.

Are there regulatory concerns for Longeveron Inc.?

The filing is a Definitive Proxy Statement (DEF 14A) filed under the Securities Exchange Act of 1934, requiring specific disclosures for shareholder votes.

Risk Factors

Industry Context

Longeveron Inc. operates in the pharmaceutical preparations industry, focusing on developing therapies.

Regulatory Implications

The filing is a Definitive Proxy Statement (DEF 14A) filed under the Securities Exchange Act of 1934, requiring specific disclosures for shareholder votes.

What Investors Should Do

  1. Review the proxy materials thoroughly to understand the implications of the proposed reverse stock split.
  2. Vote on the Reverse Stock Split Proposal and the Adjournment Proposal by the deadline.
  3. Monitor Longeveron's stock performance and future announcements following the Special Meeting.

Key Dates

Glossary

Reverse Stock Split
A stock split in which the number of shares outstanding is reduced, typically to increase the per-share price. (The primary proposal at the Special Meeting, aimed at potentially increasing the stock price.)
Certificate of Incorporation
The foundational legal document of a corporation, outlining its structure and purpose. (An amendment to this document is required to implement the reverse stock split.)

Year-Over-Year Comparison

This filing is a proxy statement (DEF 14A) related to a special meeting, distinct from routine quarterly or annual reports.

Filing Stats: 4,523 words · 18 min read · ~15 pages · Grade level 12.5 · Accepted 2024-02-05 16:50:17

Key Financial Figures

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT &#x00a0; 17 WHERE YOU CAN FIND ADDITIONAL INFORMATION &#x00a0; 19 ANNEX A &#x00a0; A-1 i LONGEVERON INC. PROXY STATEMENT FOR SPECIAL MEETING OF STOCKHOLDERS To Be Held at 1:00 p.m. Eastern Time on February 21 , 2024 This proxy statement and the enclosed form of proxy are furnished in connection with the solicitation of proxies by our Board of Directors (the &#x201c; Board &#x201d; or &#x201c; Board of Directors &#x201d;) for use at the special meeting of stockholders of Longeveron Inc., a Delaware corporation, and any postponements, adjournments or continuations thereof (the&#x00a0;&#x201c; Special Meeting &#x201d;). The Special Meeting will be held virtually on February 21 , 2024 at 1:00 p.m. Eastern Time. References in this Proxy Statement to &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;Company&#x201d; or &#x201c;Longeveron&#x201d; refer to Longeveron Inc. In addition, unless the context otherwise requires, references to &#x201c;stockholders&#x201d; are to the holders of our Class&#x00a0;A Common Stock, par value $0.001 per share and our Class&#x00a0;B Common Stock, par value $0.001 per share (collectively, our &#x201c; Common Stock &#x201d;). This proxy statement contains important information for you to consider when deciding how to vote on the matters for which we are soliciting proxies. Please read it carefully. The Special Meeting can be accessed via the Internet at www.colonialstock.com / LGVN2024 where you will be able to listen to the meeting live, submit questions, and vote online. You are entitled to participate in the Special Meeting only if you were a stockholder of the Company as of the close of business on the Record Date, or if you hold a valid proxy for the Special Meeting. No physical meeting will be held. This Proxy Statement is being made available to you because you own shares of our Common Stock as of the Record Date, which entitles

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing